SCIO Scios Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SCIO Scios Inc.

SCIO 0.01000

0.0%

Aug 19 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BRAVEHEART who wrote (964)	1/11/1999 6:36:00 PM
From: ubrx	Read Replies (1) of 1477

LoneWolf, Take a look at the company website sciosinc.com Click on investor relations and read all the press releases from the last two years. Natrecor is the product that comes before the FDA Cardiology Committee later this month. A positive recommendation will likely lead to approval within a short time. Bayer is the marketing partner on Natrecor. Scios will receive a 20 million dollar milestone payment upon FDA approval. Scios should gross about 30% in royalties on Natrecor sales. The size of the market is the subject of much debate. I have heard projections of 100-500 million per year depending on who is predicting. Short term everything depends on the Cardiology committee. Anything less than a recommendation for approval will crash the stock. Good Luck, Jim BTW, the Yahoo thread for SCIO is more active than this one and worth looking at.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next